S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)

Universal Health Services - UHS Price Target & Analyst Ratings

$101.11
+0.23 (+0.23%)
(As of 09/8/2022 11:04 AM ET)
Add
Compare
Today's Range
$99.57
$101.24
50-Day Range
$96.23
$112.64
52-Week Range
$94.70
$158.28
Volume
7,813 shs
Average Volume
638,843 shs
Market Capitalization
$7.38 billion
P/E Ratio
10.30
Dividend Yield
0.83%
Price Target
$122.87

Universal Health Services Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 13 Analyst Ratings

Consensus Analyst Price Target

$122.87
21.52% Upside
High Prediction$169.00
Average Prediction$122.87
Low Prediction$90.00
TypeCurrent
9/8/21 to 9/8/22
1 Month Ago
8/9/21 to 8/9/22
3 Months Ago
6/10/21 to 6/10/22
1 Year Ago
9/8/20 to 9/8/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
5 Sell rating(s)
5 Sell rating(s)
4 Sell rating(s)
4 Sell rating(s)
Consensus Price Target$122.87$123.00$149.27$156.50
Predicted Upside21.52% Upside5.62% Upside5.05% Upside7.32% Upside
Get Universal Health Services Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UHS and its competitors with MarketBeat's FREE daily newsletter.


UHS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UHS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Universal Health Services Stock vs. The Competition

TypeUniversal Health ServicesMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.70
2.49
Consensus RatingHoldBuyHold
Predicted Upside21.79% Upside1,250.42% Upside21.73% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
593
69.03%
Underperform Votes
266
30.97%
Avg. Outperform Votes
166
66.67%
Avg. Underperform Votes
83
33.33%
Avg. Outperform Votes
851
68.46%
Avg. Underperform Votes
392
31.54%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/6/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$129.00+34.00%
8/24/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$111.00 ➝ $115.00+11.34%
8/9/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$119.00+8.32%
7/29/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$133.00 ➝ $115.00+2.88%
7/27/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$110.00+0.56%
7/27/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$160.00 ➝ $130.00+18.87%
7/26/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$105.00-3.55%
7/12/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell$125.00 ➝ $110.00+8.57%
7/6/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform$133.00 ➝ $90.00-14.20%
7/1/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$153.00 ➝ $121.00+20.15%
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$115.00+13.26%
4/28/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$139.00 ➝ $118.00-4.52%
4/27/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$149.00 ➝ $130.00+3.73%
3/1/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$162.00 ➝ $167.00+16.03%
2/27/2022Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/14/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSell$115.00-16.39%
1/5/2021Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$144.00+6.45%
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$117.00 ➝ $139.00+4.90%
2/28/2020Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$160.00 ➝ $165.00+28.67%
(Data available from 9/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












UHS Price Target - Frequently Asked Questions

What is Universal Health Services's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Universal Health Services stock is Hold based on the current 5 sell ratings, 3 hold ratings and 5 buy ratings for UHS. The average twelve-month price prediction for Universal Health Services is $122.87 with a high price target of $169.00 and a low price target of $90.00. Learn more on UHS's analyst rating history.

Do Wall Street analysts like Universal Health Services more than its competitors?

Analysts like Universal Health Services less than other Medical companies. The consensus rating for Universal Health Services is Hold while the average consensus rating for medical companies is Buy. Learn more on how UHS compares to other companies.

Do MarketBeat users like Universal Health Services more than its competitors?

MarketBeat users like Universal Health Services more than other Medical companies. 69.03% of MarketBeat users gave Universal Health Services an outperform vote while medical companies recieve an average of 66.67% outperform votes by MarketBeat users.

Is Universal Health Services being downgraded by Wall Street analysts?

Over the previous 90 days, Universal Health Services's stock had 1 downgrade by analysts.

Does Universal Health Services's stock price have much upside?

According to analysts, Universal Health Services's stock has a predicted upside of 6.38% based on their 12-month price targets.

What analysts cover Universal Health Services?

Stock Ratings Reports and Tools

This page (NYSE:UHS) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.